Varn, F., Ye, G., Ghospurkar, P., Wade, T., Khasraw, M., Lipp, E. S., … Verhaak, R. (2022). THE LONGITUDINAL EVOLUTIONARY TRAJECTORY OF OLIGODENDROGLIOMA IS DRIVEN BY TREATMENT-ASSOCIATED GENETIC ALTERATIONS. In NEURO-ONCOLOGY (Vol. 24, pp. 152–152).

Varn, Frederick, Gordon Ye, Padmaja Ghospurkar, Taylor Wade, Mustafa Khasraw, Eric S. Lipp, Beth Hermes, et al. “THE LONGITUDINAL EVOLUTIONARY TRAJECTORY OF OLIGODENDROGLIOMA IS DRIVEN BY TREATMENT-ASSOCIATED GENETIC ALTERATIONS.” In NEURO-ONCOLOGY, 24:152–152, 2022.

Varn F, Ye G, Ghospurkar P, Wade T, Khasraw M, Lipp ES, et al. THE LONGITUDINAL EVOLUTIONARY TRAJECTORY OF OLIGODENDROGLIOMA IS DRIVEN BY TREATMENT-ASSOCIATED GENETIC ALTERATIONS. In: NEURO-ONCOLOGY. 2022. p. 152–152.

Varn, Frederick, et al. “THE LONGITUDINAL EVOLUTIONARY TRAJECTORY OF OLIGODENDROGLIOMA IS DRIVEN BY TREATMENT-ASSOCIATED GENETIC ALTERATIONS.” NEURO-ONCOLOGY, vol. 24, 2022, pp. 152–152.

Varn F, Ye G, Ghospurkar P, Wade T, Khasraw M, Lipp ES, Hermes B, Elliott C, Costello JF, Hong C, French P, Vallentgoed W, Padovan M, Ng H-K, Li K, Gan H, Westcott K, Vaubel R, Horbinski C, McCortney K, Paek SH, Moon H-E, LaViolette P, Lowman A, Barnholtz-Sloan J, Wesseling P, Verhaak R. THE LONGITUDINAL EVOLUTIONARY TRAJECTORY OF OLIGODENDROGLIOMA IS DRIVEN BY TREATMENT-ASSOCIATED GENETIC ALTERATIONS. NEURO-ONCOLOGY. 2022. p. 152–152.